Key Sessions
Wolfram Carius
Keynote Panel Discussion: Big Pharma’s CGT Playbook - Top Investment Priorities and Emerging Opportunities
Bayer
Tuesday 16th September, 2025 - Workshop & Keynotes - ET (Eastern Time, GMT-05:00)
Tuesday 16th September, 2025 - Workshop & Keynotes - ET (Eastern Time, GMT-05:00)
8:00am - 9:00am60 mins
Registration Break
Registration and Morning Coffee
9:00am - 10:30am90 mins
Workshop: Potency Masterclass
Potency Masterclass
9:00am - 10:30am90 mins
Workshop: Mastering CDMO Partnerships & External Tech Transfers for Cell & Gene Therapies
Mastering CDMO Partnerships & External Tech Transfers for Cell & Gene Therapies
- James Blackwell - President and Principal Consultant, The Windshire Group, LLC
- Tracy Payne - SVP Business Development, Principal Consultant Business Strategy & Operations, Windshire Group, LLC. Labshire, LLC
10:30am - 11:00am30 mins
Break
Morning Coffee Break
11:00am - 12:45pm105 mins
Workshop: Potency Masterclass
Potency Masterclass
11:00am - 12:45pm105 mins
Workshop: Mastering CDMO Partnerships & External Tech Transfers for Cell & Gene Therapies
Mastering CDMO Partnerships & External Tech Transfers for Cell & Gene Therapies
- James Blackwell - President and Principal Consultant, The Windshire Group, LLC
- Tracy Payne - SVP Business Development, Principal Consultant Business Strategy & Operations, Windshire Group, LLC. Labshire, LLC
11:00am - 12:45pm105 mins
CGT C-Level Forum
CGT C-Level Forum - Invite Only
11:00am - 12:45pm105 mins
CGT Supply Chain Forum
CGT Supply Chain Forum - Invite Only
12:45pm - 1:00pm15 mins
Break
Transition to Lunch Presentations
1:00pm - 1:45pm45 mins
Scientific Lunch Presentation 5
'Lunch n Learn' Presentation by Advanced Instruments
1:00pm - 1:45pm45 mins
Scientific Lunch Presentation 7
Lunch Slot 7
1:00pm - 1:45pm45 mins
Scientific Lunch Presentation 8
Lunch Slot 8
1:45pm - 2:00pm15 mins
Break
Lunch Networking
2:00pm - 2:05pm5 mins
Keynote Plenary
Welcome to Cell and Gene Therapy International and Chairperson’s Opening Remarks
2:05pm - 2:50pm45 mins
Keynote Plenary
Keynote Panel Discussion: Big Pharma’s CGT Playbook - Top Investment Priorities and Emerging Opportunities
- Wolfram Carius - EVP Pharmaceuticals, Bayer
- Erin Kimbrel - President & Head, Astellas Institute for Regenerative Medicine
- Stephen Kennedy - Head of Technical Operations, CRISPR Therapeutics
- Ruth Salmon - VP, BMS Cell Therapy Research, Bristol Myers Squibb
2:50pm - 3:30pm40 mins
Keynote Plenary
Investor Panel Discussion: Investments in Cell and Gene Therapies and Enabling Technologies
- Bryan Poltilove - Strategic Advisor and Independent Board Director, Independent
- Daniel Friedman - Principal, BroadOak Capital
- Aaron Fisher - Director, Life Sciences Investments, ARCHIMED
3:30pm - 4:30pm60 mins
Break and Exhibition Hall Opening
Afternoon Break and Grand Opening of the Exhibit Hall
4:30pm - 5:10pm40 mins
Keynote Plenary
Keynote Presentation and Fire Side Chat: Lessons Learnt of the Path to Commercialization
5:10pm - 5:30pm20 mins
Keynote Plenary
Building Customer Confidence and Reducing Risk with Early Access to Development Teams
- Sara Miller - Director, Advanced Therapies Commercial Technical Lead, FUJIFILM Diosynth Biotechnologies
5:30pm - 7:00pm90 mins
Break
Networking Reception in the Exhibit Hall
7:00pm - 7:05pm5 mins
Break
Close of Day One
* 不測の事態により、事前の予告なしにプログラムが変更される場合があります。